Response to nutritional support and therapeutic approaches of amino acid and protein metabolism in surgical patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue S4, 2013, Pages 123-130

  Sakurai, Yoichi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anabolic hormones; Critical illness; Nutritional support; Protein metabolism

Indexed keywords

AMINO ACID METABOLISM; ARTICLE; CRITICAL ILLNESS; DIET THERAPY; ENTERIC FEEDING; HUMAN; METABOLIC REGULATION; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN METABOLISM; SURGICAL PATIENT; TOTAL PARENTERAL NUTRITION;

ANABOLIC HORMONES; CRITICAL ILLNESS; NUTRITIONAL SUPPORT; PROTEIN METABOLISM;

AMINO ACIDS; BIOLOGICAL TRANSPORT; BLOOD CELL COUNT; CELL MEMBRANE; CRITICAL ILLNESS; ENERGY INTAKE; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; INSULIN; MUSCLE, SKELETAL; PARENTERAL NUTRITION; PERIOPERATIVE CARE; PROTEINS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84897603688     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12405     Document Type: Article

References (105)

1. Shaw JH, Wolfe RR. An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. Ann. Surg. 1989; 209: 63-72.
2. Shaw JH, Wolfe RR. Energy and protein metabolism in sepsis and trauma. Aust. N. Z. J. Surg. 1987; 57: 41-47.
3. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metab. Clin. Exp. 1979; 28: 1031-1039.
4. Wolfe RR, O'Donnell TF Jr, Stone MD, Richmand DA, Burke JF. Investigation of factors determining optimal glucose infusion rate in total parenteral nutrition. Metab. Clin. Exp. 1980; 29: 892-900.
5. Shaw JHF, Wolfe RR. Response to glucose and lipid infusions in sepsis. A kinetic analysis. Metab. Clin. Exp. 1985; 34: 442-449.
6. Wolfe RR, Shaw JHF. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity. Am. J. Physiol. 1985; 248: E236-243.
7. Shaw JH, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding. Ann. Surg. 1987; 205: 368-376.
8. Shaw JH, Wolfe RR. Whole-body protein kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and total parenteral nutrition. Surgery 1988; 103: 148-155.
9. Sakurai Y, Klein S. Metabolic alteration in patients with cancer-nutritional implications. Surg. Today 1998; 28: 247-257.
10. Kinney JM. Metabolic responses to injuries. In: Winters RW, Green HL, eds. Nutritional Support of the Seriously Ill Patient. New York: Academic Press, 1983; 5-12.
11. Wolfe RR, Goodenough RD, Burke JF, Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann. Surg. 1983; 197: 163-171.
12. Shangraw RE, Stuart CA, Prince MJ, Peters EJ, Wolfe RR. Insulin responsiveness of protein metabolism in vivo following bedrest in humans. Am. J. Physiol. 1988; 255: E548-558.
13. Shangraw RE, Jahoor F, Miyoshi H etal. Differentiation between septic and postburn insulin resistance. Metab. Clin. Exp. 1989; 38: 983-989.
14. Jahoor F, Shangraw RE, Miyoshi H, Wallfish H, Herndon DN, Wolfe RR. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am. J. Physiol. 1989; 257: E323-331.
15. Wolfe RR, Jahoor F, Herndon DN, Miyoshi H. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery 1991; 110: 54-67.
16. Wolfe RR, Jahoor F, Hartl WH. Protein and amino acid metabolism after injury. Diabetes Metab. Rev. 1989; 5: 149-164.
17. Bilmazes C, Kien CL, Rohrbaugh DK etal. Quantitative contribution by skeletal muscle to elevated rates of whole-body protein breakdown in burned children as measured by N tau-methylhistidine output. Metab. Clin. Exp. 1978; 27: 671-676.
18. Long CL, Birkhahn RG, Gieiger JW, Betls JE, Schiller WR, Blahemore WR. Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma. Metab. Clin. Exp. 1981; 30: 765-776.
19. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF. Cancer cachexia and protein metabolism. Lancet 1984; 1: 1423-1426.
20. Burt ME, Stein TP, Brennan MF. A controlled, randomized trial evaluating the effects of enteral and parenteral nutrition on protein metabolism in cancer bearing man. J. Surg. Res. 1983; 34: 303-314.
21. Shaw JH, Wolfe RR. Whole-body protein kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and total parenteral nutrition. Surgery 1988; 103: 148-155.
22. Shaw JH, Wolfe RR. Metabolic intervention in surgical patients. An assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes. Ann. Surg. 1988; 207: 274-282.
23. Wolfe RR. Counterregulatory hormones and human protein metabolism. In: Nair KS, ed. Protein Metabolism in Diabetes Mellitus. Alberta: Smith Gordon & Company, 1992; 207-213.
24. Moldawer LL, Svaninger G, Gelin J, Lundholm KG. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 1987; 253: C766-773.
25. Hasselgren PO, Warner BW, James JH, Takehara H, Fischer JE. Effect of insulin on amino acid uptake and protein turnover in skeletal muscle from septic rats. Evidence for insulin resistance of protein breakdown. Arch. Surg. 1987; 122: 228-233.
26. Inculet RI, Finley RJ, Duff JH etal. Insulin decreases muscle protein loss after operative trauma in man. Surgery 1986; 99: 752-758.
27. Ryan NT, Blackburn GL, Clows GHA. Differential tissue sensitivity to elevated endogenous insulin levels during experimental peritonitis in rats. Metab. Clin. Exp. 1974; 23: 1081-1089.
28. Ryan NT, George BC, Egdahl DH, Egdahl RH. Chronic tissue insulin resistance following hemorrhagic shock. Ann. Surg. 1974; 180: 402-407.
29. Sakurai Y, Ochiai M, Funabiki T. Assessment of in vivo glucose kinetics using stable isotope tracers to determine their alteration in human during critical illness. Surg. Today 2000; 30: 1-10.
30. Clowes GHA, O'Donnell TF, Blackburn GL, Maki TN. Energy metabolism and proteolysis in traumatized and septic man. Surg. Clin. North Am. 1976; 56: 1169-1184.
31. Gump FE, Kinney JM. Energy balance and weight loss in burned patients. Arch. Surg. 1971; 103: 442-448.
32. Ryan NT. Metabolic adaptations for energy production during trauma and sepsis. Surg. Clin. North Am. 1976; 56: 1073-1090.
33. Wilmore DW. Hormonal responses and their effect on metabolism. Surg. Clin. North Am. 1976; 56: 999-1018.
34. Bessey PQ, Watters JM, Aoki TT, Wilmore DW. Combined hormonal infusion simulates the metabolic response to injury. Ann. Surg. 1984; 200: 264-281.
35. Burt ME, Aoki TT, Gorschboth CM, Brennan MF. Peripheral tissue metabolism in cancer-bearing man. Ann. Surg. 1983; 198: 685-691.
36. Sakurai Y, Zhang X, Wolfe RR. Short-term effects of tumor necrosis factor on energy and substrate metabolism in dogs. J. Clin. Invest. 1993; 91: 2437-2445.
37. Sakurai Y, Zhang X, Wolfe RR. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am. J. Physiol. 1994; 266: E936-945.
38. Stovroff MC, Fraker DL, Norton JA. Cachectin activity in the serum of cachectic, tumor-bearing rats. Arch. Surg. 1989; 124: 94-99.
39. Tracey KJ, Wei H, Manogue KR etal. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 1988; 167: 1211-1227.
40. Hesse DG, Tracey KJ, Fong Y etal. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 1988; 166: 147-153.
41. Tracey KJ, Lowry SF, Fahey TJ III etal. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 1987; 164: 415-422.
42. Van del poll T, Romijn JA, Endert E, Borm JJJ, Büller HR, Sauerwein HP. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am. J. Physiol. 1991; 261: E457-465.
43. Bellomo R. The cytokine network in the critically ill. Anaesth. Intensive Care 1992; 20: 288-302.
44. Manary MJ, Yarasheski KE, Berger R, Abrams ET, Hart CA, Broardhead RL. Whole-body leucine kinetics and the acute phase response during acute infection in marasmic Malawian children. Pediatr. Res. 2004; 55: 940-946.
45. James JH, Hasselgren PO, Hummel RP III, Warner BW, Fischer JE. Effect of sepsis on amino acid transport system A and its response to insulin in incubated rat skeletal muscle. Metab. Clin. Exp. 1990; 39: 335-340.
46. Dudrick PS, Bland KI, Souba WW. Effects of tumor necrosis factor on system ASC-mediated glutamine transport by human fibroblasts. J. Surg. Res. 1992; 52: 347-352.
47. Biolo G, Fleming RYD, Maggi SP, Wolfe RR. Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle. Am. J. Physiol. 1995; 268: E75-84.
48. Flakoll PJ, Kulaylat M, Frexes-Steed M etal. Amino acids augment insulin's suppression of whole body proteolysis. Am. J. Physiol. 1989; 257: E839-847.
49. Biolo G, Chinkes D, Zhang XJ, Wolfe RR. A new model to determine in vivo the relationship between amino acid transmembrane transport and protein kinetics in muscle. JPEN J. Parenter. Enteral Nutr. 1992; 16: 305-315.
50. Biolo G, Maggi SP, Williams BD, Tipton KD, Wolfe RR. Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am. J. Physiol. 1995; 268: E514-520.
51. Biolo G, Maggi SP, Fleming RYD, Herndon DN, Wolfe RR. Relationship between transmembrane amino acid transport and protein kinetics in muscle tissue of severely burned patients. Clin. Nutr. 1993; 12 (Suppl. 2): 4. Abstract.
52. Sakurai Y, Wolfe RR, Herndon DN, Funabiki T. Effects of long-term high-carbohydrate enteral feeding on transmembrane amino acid transport in severely burned patients. Surg. Forum 1996; 47: 29-31.
53. Sakurai Y, Aarsland A, Chinkes DL etal. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann. Surg. 1995; 222: 283-297.
54. Jahoor F, Desai M, Herndon DN, Wolfe RR. Dynamics of the protein metabolic response to burn injury. Metab. Clin. Exp. 1988; 37: 330-337.
55. Wilmore DW, Moylan JA Jr, Bristow BF, Mason AD Jr, Pruitt BA Jr Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg. Gynecol. Obstet. 1974; 138: 875-884.
56. Manson JM, Smith RJ, Wilmore DW. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment. Ann. Surg. 1988; 208: 136-142.
57. Brooks DC, Bessey PQ, Black PR, Aoki TT, Wilmore DW. Insulin stimulates branched chain amino acid uptake and diminishes nitrogen flux from skeletal muscle of injured patients. J. Surg. Res. 1986; 40: 395-405.
58. Ziegler TR, Young LS, Ferrari Baliviera E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN J. Parenter. Enteral Nutr. 1990; 14: 574-581.
59. Herndon DN, Hayward PG, Rutan RL, Barrow RE. Growth hormones and factors in surgical patients. Adv. Surg. 1992; 25: 65-97.
60. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch. Surg. 1991; 126: 38-43.
61. Cioffi WG, Gore DC, Rue LW III etal. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann. Surg. 1994; 220: 310-319.
62. Fukagawa NK, Minaker KL, Rowe JW etal. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J. Clin. Invest. 1985; 76: 2306-2311.
63. Tessari P, Trevisan R, Inchiostro S etal. Dose-response curves of effects of insulin on leucine kinetics in humans. Am. J. Physiol. 1986; 251: E334-342.
64. Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 1987; 80: 1-6.
65. Powell-Tuck J, Fern EB, Garlick PJ, Waterlow JC. The effect of surgical trauma and insulin on whole-body protein turnover in parenterally-fed undernourished patients. Hum. Nutr. Clin. Nutr. 1984; 38: 11-22.
66. Biolo G, Fleming RYD, Wolfe RR. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J. Clin. Invest. 1995; 95: 811-819.
67. Guidotti GG, Borghetti AF, Gazzola GC. The regulation of amino acid transport in animal cells. Biochim. Biophys. Acta 1978; 515: 329-366.
68. Shotwell MA, Kilberg MS, Oxender DL. The regulation of neutral amino acid transport in mammalian cells. Biochim. Biophys. Acta 1983; 737: 267-284.
69. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 1990; 70: 43-77.
70. Hundal HS, Rennie MJ, Watt PW. Characteristics of acidic, basic and neutral amino acid transport in the perfused rat hindlimb. J. Physiol. 1989; 408: 93-114.
71. Guidotti GG, Gazzola GC. Amino acid transporters: systematic approach and principles of controls. In: Kilberg MS, Haüssinger D, eds. Mammalian Amino Acid Transport. New York: Plenum Publishing Corp., 1992; 3-29.
72. Bonadonna RC, Saccomani MP, Cobelli C, DeFronzo RA. Effect of insulin on system A amino acid transport in human skeletal muscle. J. Clin. Invest. 1993; 91: 514-521.
73. Janssen JA. Advantages and disadvantages of GH/IGF-I combination treatment. Rev. Endocr. Metab. Disord. 2009; 10: 157-162.
74. Marik PE. Glycemic comtrol in critically ill patients: what to do post NICE-SUGAR? World J Gastrointest. Surg. 2009; 30: 3-5.
75. Deitch EA, Berg R. Bacterial translocation from the gut: a mechanism of infection. J. Burn Care Rehabil. 1987; 8: 475-482.
76. Spaeth G, Specian RD, Berg RD, Deitch EA. Bulk prevents bacterial translocation induced by the oral administration of total parenteral nutrition solution. JPEN J. Parenter. Enteral Nutr. 1990; 14: 442-447.
77. Aiko S, Yoshizumi Y, Sugiura Y etal. Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg. Today 2001; 31: 971-978.
78. Mercer CD, Mungara A. Enteral feeding in esophageal surgery. Nutrition 1996; 12: 200-201.
79. Gabor S, Renner H, Matzi V etal. Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br. J. Nutr. 2005; 93: 509-513.
80. Ryan AM, Rowley SP, Healy LA, Flood PM, Ravi N, Reynolds JV. Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit. Clin. Nutr. 2006; 25: 386-393.
81. Mesejo A, Acosta JA, Ortega C etal. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin. Nutr. 2005; 22: 295-305.
82. Coulston AM. Clinical experience with modified enteral formulas for patients with diabetes. Clin. Nutr. 1998; 17 (Suppl. 2): 46-56.
83. Craig LD, Nicholson S, SilVerstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 1998; 14: 529-534.
84. Cerra FB, Lehmann S, Konstantinides N etal. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition 1991; 7: 193-199.
85. Barbul A. Arginine: biochemistry, physiology, the therapeutic implications. J. Parent. Enter. Nutr. 1986; 10: 227-238.
86. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr. Rev. 1990; 48: 297-309.
87. Pastores SM, Kvetan V, Katz DP. Immunomodulatory effects and therapeutic potential of glutamine in the critically ill surgical patient. Nutrition 1994; 10: 385-391.
88. Almallah YZ, Ewen SW, El-Tahir A etal. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 2000; 20: 68-76.
89. Dichi I, Frenhane P, Dichi JB etal. Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 2000; 16: 87-90.
90. Carver JD, Cox WI, Barness LA. Dietary nucleotide effects upon murine natural killer cell activity and macrophage activation. J. Parenter. Enteral. Nutr. 1990; 14: 18-22.
91. Yamauchi K, Adjei AA, Ameho CK etal. A nucleoside-nucleotide mixture and its components increase lymphoproliferative and delayed hypersensitivity responses in mice. J. Nutr. 1996; 126: 1571-1577.
92. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit. Care Med. 1998; 26: 1164-1172.
93. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit. Care Med. 1999; 27: 2799-2805.
94. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann. Surg. 1999; 229: 467-477.
95. Braga M, Gianotti L, Cestari A etal. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch. Surg. 1996; 131: 1257-1264.
96. Furukawa K, Tashiro T, Yamamori H etal. Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann. Surg. 1999; 229: 255-261.
97. Aiko S, Yoshizumi Y, Tsuwano S, Shimanouchi M, Sugiura Y, Maehara T. The effects of immediate enteral feeding with a formula containing high levels of omega-3 fatty acids in patients after surgery for esophageal cancer. JPEN J. Parenter. Enteral Nutr. 2005; 29: 141-147.
98. Gadek JE, DeMichele SJ, Karlstad MD etal. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit. Care Med. 1999; 27: 1409-1420.
99. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit. Care Med. 2006; 34: 1033-1038.
100. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit. Care Med. 2006; 34: 2325-2333.
101. Suchner U, Heyland DK, Peter K. Immune-modulatory actions of arginine in the critically ill. Br. J. Nutr. 2002; 87 (Suppl. 1): S121-132.
102. Sakurai Y, Oh-Oka Y, Kato S etal. Effects of long-term continuous use of immune-enhancing enteral formula on nutritional and immunologic status in non-surgical patients. Nutrition 2006; 22: 713-721.
103. Sakurai Y, Masui T, Yoshida I etal. Randomized clinical trial of the effects of perioperative use of immune-enhancing enteral formula on metabolic and immunological status in patients undergoing esophagectomy. World J. Surg. 2007; 31: 2150-2157.
104. Sakurai Y, Kanaya S, Uyama I. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy? Esophagus 2009; 6: 149-154.
105. Takeuchi H, Ikeuchi S, Kawaguchi Y etal. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J. Surg. 2007; 31: 2160-2167.